Papaverine Hydrochloride Solution For Injection 30Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Papaverine Hydrochloride: Solution for injection (30mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PAPAVERINE (pa PAV er een) is a vasodilator. It relaxes the blood vessels which makes it easier for blood to pass through them. It is used to treat certain conditions that cause blood vessels to spasm. This medicine may also be used to relieve the spasms associated with urinary tract, gallbladder or stomach.

In-Depth Information
Select a Medication

Papaverine Hydrochloride 30mg/ml Solution for Injection

NDC: 005174002
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Arterial Thromboembolism

Sometimes used for but not FDA approved for the following conditions:
Acute Myocardial Infarction, Angina, Erectile Dysfunction (ED)

Storage Information
Protect from light
Store in carton until time of use
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Papaverine Hydrochloride 30mg/ml Solution for Injection

Reported Side Effects for Papaverine Hydrochloride 30mg/ml Solution for Injection

Liver Disease Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Long Qt Syndrome Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Torsade De Pointes Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Papaverine Hydrochloride

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5